The aim of this study was to evaluate the role of SPHK1 in anti-tumor immunity, reveal the novel molecular mechanism of PD-L1 regulation through MMP1, and further explore the clinical significance of the SPHK1-MMP1 axis in HNSCC immunotherapy. The gene discussed is MMP1; the disease is head and neck squamous cell carcinoma.